EUVIMEDEUVIMED entdecken
Crossref

Lateral needle placement using 3D-printed ovoid-based needle guides mitigates the negative impact of high T-score cervical cancer

Santino Butler, Thomas Niedermayr, Elizabeth Kidd

Brachytherapy · 2026-07 · 25 (4) · 624-631

DOI: 10.1016/j.brachy.2026.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brachytherapy, 2026-07. Verfasst von Santino Butler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Brachytherapy, Needles, Printing, Three-Dimensional. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND To aid brachytherapy needle placement for wide cervical tumors, we designed a three-dimensional-printed ovoid-based needle guide (OVI). This study aimed to evaluate dosimetric advantages with OVI and determine which patients may benefit most. METHODS This single-institution cohort study included 106 curative-intent cervical intracavity/interstitial brachytherapy implants (N = 95 OVI, N = 11 non-OVI) across 27 patients from 2020 to 2025. Predicted cumulative doses in 2-Gy-fraction-equivalents (EQD2) were calculated per implant, across needle-guide type and T-score (EMBRACE-validated prognostic tumor score). RESULTS Seventy percent received OVI for all implants (full-OVI); 30% received both OVI and non-OVI implants (partial-OVI)-with no significant differences in baseline features. Overall, 63% had FIGO stage III-IV disease, 70% had high-risk clinical target volume (HR-CTV) volume >30 cc (median, 38.3 cc), and 37% had high T-scores ≥10; mean HR-CTV width at cervical os was 5.1 cm. OVI (vs. non-OVI) implants achieved 9.1 GyEQD2 higher mean HR-CTV D90 (89.2 vs. 80.1 GyEQD2, p 85 GyEQD2 (86% vs. 18%; adjusted hazard ratio 11.4, p = 0.042)-with comparable mean D2cc to all normal tissues. Similar results were seen in "partial-OVI" subgroup. High T-score ≥10 was the most significant independent predictor for lower HR-CTV D90. There was a significant interaction between high T-score and needle guide type: T-score ≥10 tumors had an 8.4 GyEQD2 lower mean D90 with non-OVI implants but only a 2.1-GyEQD2 lower mean D90 with OVI implants (net +6.3 GyEQD2; pinteraction = 0.021). CONCLUSIONS OVI enabled greater HR-CTV dose while maintaining similar dose to normal tissues. OVI particularly benefited high T-score tumors and made up for the HR-CTV D90 detriment seen in this group. These data demonstrate three-dimensional-printed tools as one additional method in facilitating needle placement for complex brachytherapy cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsBrachytherapyNeedlesPrinting, Three-DimensionalHumansFemaleMiddle AgedAgedAdultRadiotherapy DosageCohort Studies

Stichwörter der Autor:innen

BrachytherapyCervical cancerHybrid brachytherapyInterstitial needlesUterine cervical neoplasms

Autor:innen und Institutionen

  • Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA.
  • Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA. Electronic address: ekidd@stanford.edu.

Zitieren

APA

Butler, S., Niedermayr, T., & Kidd, E. (2026). Lateral needle placement using 3D-printed ovoid-based needle guides mitigates the negative impact of high T-score cervical cancer. Brachytherapy, 25(4), 624-631. https://doi.org/10.1016/j.brachy.2026.02.004

Vancouver

Butler S, Niedermayr T, Kidd E. Lateral needle placement using 3D-printed ovoid-based needle guides mitigates the negative impact of high T-score cervical cancer. Brachytherapy. 2026;25(4):624-631. doi:10.1016/j.brachy.2026.02.004

BibTeX
@article{Butler2026,
  author = {Butler, Santino and Niedermayr, Thomas and Kidd, Elizabeth},
  title = {Lateral needle placement using 3D-printed ovoid-based needle guides mitigates the negative impact of high T-score cervical cancer},
  journal = {Brachytherapy},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {624--631},
  doi = {10.1016/j.brachy.2026.02.004}
}
Kostenlos starten →